2018
Risk ratios for contagious outcomes
Morozova O, Cohen T, Crawford FW. Risk ratios for contagious outcomes. Journal Of The Royal Society Interface 2018, 15: 20170696. PMID: 29343627, PMCID: PMC5805970, DOI: 10.1098/rsif.2017.0696.Peer-Reviewed Original Research
2017
HIV Risk, Prevalence, and Access to Care Among Men Who Have Sex with Men in Lebanon
Heimer R, Barbour R, Khouri D, Crawford FW, Shebl F, Aaraj E, Khoshnood K. HIV Risk, Prevalence, and Access to Care Among Men Who Have Sex with Men in Lebanon. AIDS Research And Human Retroviruses 2017, 33: 1149-1154. PMID: 28540733, PMCID: PMC6913106, DOI: 10.1089/aid.2016.0326.Peer-Reviewed Original ResearchConceptsHIV testingHIV prevalenceExperiences of stigmaGroup sex encounterAnonymous HIV testingCases of HIVSpread of HIVNational-level surveillanceSpecific risk behaviorsSociodemographic situationRespondent-driven samplingAntiretroviral therapyHIV diagnosisHIV riskCondomless sexDrug useCondom useRisk behaviorsPrevalenceInterview questionnaireMSMMenSexual behaviorHIVBiobehavioral studies
2016
Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic
Kunkel A, Crawford FW, Shepherd J, Cohen T. Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic. AIDS 2016, 30: 2715-2723. PMID: 27782966, PMCID: PMC5089846, DOI: 10.1097/qad.0000000000001235.Peer-Reviewed Original ResearchConceptsContinuous isoniazid preventive therapyIsoniazid preventive therapyIsoniazid-resistant tuberculosisTB epidemicPreventive therapyEffective TB treatmentLatent TB infectionTB drug resistanceTransmission dynamic modelTB infectionMortality benefitTB treatmentHIV controlHIV incidenceTB incidenceTB transmissionCase findingDrug resistanceIncidenceTuberculosisInitial benefitPLHIVHIVTherapyEpidemic